Litigation Details for Amyris, Inc. (Bankr. D. Del. 2023)
✉ Email this page to a colleague
Amyris, Inc. (Bankr. D. Del. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-08-09 |
| Court | United States Bankruptcy Court, D. Delaware | Date Terminated | |
| Cause | Assigned To | Thomas M. Horan | |
| Jury Demand | Referred To | ||
| Patents | 10,533,041; 6,005,001; 7,579,019; 7,777,050; 7,872,050; 7,897,050; 8,008,006; 8,546,136; 9,000,011; 9,701,971 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amyris, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Amyris, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Amyris, Inc. (Bankr. D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-01-22 | 1177 | Declaration in Support | 90.4% 51.1% 21.4% 5.6% 5.1% EBITDA … the patent; (b) an estimated duration of the patent’s useful life; (c) consideration of patent specific… for valuing patents because, by definition, patents are unique and there are no patents that are directly…August 9, 2023, the value of certain of Amyris’ patents, trade secrets, know how, brands, and trademarks… Amyris generates value through the use of its patents in manufacturing ingredients made with | External link to document |
| 2023-11-01 | 663 | Exhibit A | $10,533.41 TOTAL CURRENT CHARGES … $10,533.41 Case 23-11131-TMH Doc… $10,533.41 Amyris, Inc. 9… discussion concerning patent treatment. 08/21/2023 HCK AA Conference…negotiations 08/15/2023 DG EC Call with Patent counsel from Goodwin re: 0.50 1,550.00 | External link to document |
| 2023-08-14 | 75 | Exhibit A - Motion | 9,410 94 23,182 15,367 7,579 19,804 16,026 11,207 9,151 …9,410 94 23,182 15,367 7,579 19,804 16,026 11,207 9,151 …and Perrara, dated as of March 10, 2023; (iii) Patent Security Agreement, by and between Amyris, the …Grantors, and Anesma, dated as of June 5, 2023; (vi) Patent Security Agreement, by and between Amyris, the…Grantors, and Anesma, dated as of June 5, 2023; (viii) Patent Security Agreement by and between Amyris, the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
